- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Phenylketonuria (PKU)
- Meeting Date: July 2026
Pegvaliase – July 2026
Public Summary Documents
Related Public Summary Documents
Last updated
12 November 2026
